RecallDepth
Class II Terminated

Quinapril Tablets USP, 20 mg (90 pack), Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, by: Lupin Limited, Goa 403 722 India, NDC# 68180-558-09

Company
Lupin Pharmaceuticals Inc.
Recall Initiated
December 7, 2022
Posted
December 28, 2022
Recall Number
D-0089-2023
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
23,736
Firm Location
Baltimore, MD, United States

Reason for Recall

CGMP Deviations: Detection of N-Nitroso-quinapril impurity above the acceptable daily intake limit.

Distribution

Product was distributed by major distribution chains nationwide.

Lot / Code Info

Lot #: G102929, Exp 04/2023

More recalls by Lupin Pharmaceuticals Inc.

View all recalls by this company →

Other recent Class II Drug recalls